...
首页> 外文期刊>Tissue engineering, Part A >Combined transplantation of bone marrow stromal cell-derived neural progenitor cells with a collagen sponge and basic fibroblast growth factor releasing microspheres enhances recovery after cerebral ischemia in rats.
【24h】

Combined transplantation of bone marrow stromal cell-derived neural progenitor cells with a collagen sponge and basic fibroblast growth factor releasing microspheres enhances recovery after cerebral ischemia in rats.

机译:骨髓基质细胞衍生的神经祖细胞与胶原海绵和碱性成纤维细胞生长因子释放微球的联合移植可增强大鼠脑缺血后的恢复。

获取原文
获取原文并翻译 | 示例
           

摘要

Bone marrow stromal cells (MSCs) are a useful source of cells because of their abundant supply and few associated ethical problems. We have previously reported that neural progenitor cells (NS-MSCs) can be effectively induced from MSCs and differentiate into neurons to contribute to functional recovery when transplanted into the rat stroke model. In this study, we attempted to enhance the therapeutic effects of NS-MSCs with a collagen sponge and basic fibroblast growth factor (bFGF) releasing microspheres. NS-MSCs were generated from MSCs by transfection of Notch-1 intracellular domain followed by culturing the cells in a free-floating culture system. The resulting NS-MSCs were transplanted into the rats with induced brain ischemia by using collagen sponges as scaffolds for transplanted cells, and with bFGF incorporated into gelatin microspheres to aid neovascularization around the transplanted region and proliferation of neural stem cellseural progenitor cells. In culture, NS-MSCs successfully formed spheres containing cells highly expressing neural progenitor markers. Cell survival, neovascularization, and proliferation of host neural stem cellseural progenitor cells were improved in animals that received NS-MSCs together with these biomaterials. Behavioral analysis also revealed significant functional recovery. These observations demonstrate that transplantation of NS-MSCs in combination with a collagen sponge and bFGF releasing microspheres significantly improves histological and functional recovery in the rat stroke model. When used with these biomaterials, NS-MSCs would be a promising cell source for treating stroke and neurodegenerative diseases.
机译:骨髓基质细胞(MSC)是一种有用的细胞来源,因为它们的供应充足且几乎没有相关的伦理问题。我们以前曾报道过,神经祖细胞(NS-MSC)可以从MSC中有效诱导并分化为神经元,从而在移植到大鼠中风模型中时有助于功能恢复。在这项研究中,我们试图用胶原海绵和释放碱性成纤维细胞生长因子(bFGF)的微球增强NS-MSC的治疗效果。通过转染Notch-1细胞内结构域,然后在自由漂浮的培养系统中培养细胞,从MSC产生NS-MSC。通过使用胶原海绵作为移植细胞的支架,并将bFGF掺入明胶微球中,以协助移植区域周围的新生血管形成和神经干细胞/神经祖细胞的增殖,将所得的NS-MSCs移植到诱发脑缺血的大鼠中。在培养中,NS-MSC成功地形成了含有高表达神经祖细胞标记物的细胞的球体。接受NS-MSC和这些生物材料的动物的细胞存活,新血管形成和宿主神经干细胞/神经祖细胞的增殖得到改善。行为分析还显示出明显的功能恢复。这些观察结果表明,将NS-MSC与胶原海绵和释放bFGF的微球联合移植可显着改善大鼠中风模型的组织学和功能恢复。当与这些生物材料一起使用时,NS-MSC将成为治疗中风和神经退行性疾病的有前途的细胞来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号